Back

State of the art in device-based therapies for hypertension

29 August 2016 (14:00 - 14:18)
Organised by:
Congress Presentation Part of: Device-based treatments for hypertension Devices / interventions ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Konstantinos Tsioufis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Controlling and lowering blood pressure with the MobiusHD device: first-in-man interim results (CALM-FIM study)
Doctor W. Spiering (Utrecht, NL)
Abstract
Presentation thumbnail
Effect of renal denervation on blood pressure levels and clinical course of obstructive sleep apnea in patients with resistant hypertension - 3 months outcomes of randomized trial
Doctor E. Warchol-Celinska (Warsaw, PL)
Abstract
Presentation thumbnail
Effects of percutaneous transluminal renal angioplasty on office and home blood pressure and home blood pressure variability in hypertensive patients with renal artery stenosis
Doctor Y. Iwashima (Osaka, JP)
Abstract
Presentation thumbnail
Future direction for research in device-based therapies for hypertension.
Professor F. Mahfoud (Basel, CH)
Slides Video

Access the full session

Session thumbnail
Device-based treatments for hypertension

The Event

Event poster

ESC Congress 2016

29 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on device-based hypertension management
30 August 2024
thumbnail
Congress Session
Which device might help your HFpEF patient?
20 May 2025
thumbnail
Congress Presentation
Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.
5 April 2025
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources